Literature DB >> 1303231

Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A.

N Matsunami1, B Smith, L Ballard, M W Lensch, M Robertson, H Albertsen, C O Hanemann, H W Müller, T D Bird, R White.   

Abstract

Charcot-Marie-Tooth disease 1A (CMT1A) is a hereditary demyelinating peripheral neuropathy, associated with a DNA duplication on chromosome 17p11.2. A related disorder in the mouse, trembler (Tr), maps to mouse chromosome 11 which has syntenic homology to human chromosome 17p. Recently, the peripheral myelin protein-22 (pmp-22) gene was identified as the likely Tr locus. We have constructed a partial yeast artificial chromosome contig spanning the CMT1A gene region and mapped the PMP-22 gene to the duplicated region. These observations further implicate PMP-22 as a candidate gene for CMT1A, and suggest that over-expression of this gene may be one mechanism that produces the CMT1A phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1303231     DOI: 10.1038/ng0692-176

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  63 in total

Review 1.  Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.

Authors:  Gerd Meyer zu Hörste; Thomas Prukop; Klaus-Armin Nave; Michael W Sereda
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Hereditary neuropathy with liability to pressure palsies: the same molecular defect can result in diverse clinical presentation.

Authors:  E Andreadou; C Yapijakis; G P Paraskevas; P Stavropoulos; C Karadimas; V P Zis; P Davaki; N Karandreas; M Rentzos; C Tsakanikas; D Vassilopoulos; C Papageorgiou
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

3.  A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe de novo Charcot-Marie-Tooth disease.

Authors:  R Navon; B Seifried; N S Gal-On; M Sadeh
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

4.  Current Therapy for Charcot-Marie-Tooth Disease.

Authors:  Marina Grandis; Michael E Shy
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.598

5.  Neurons promote the translocation of peripheral myelin protein 22 into myelin.

Authors:  S Pareek; L Notterpek; G J Snipes; R Naef; W Sossin; J Laliberté; S Iacampo; U Suter; E M Shooter; R A Murphy
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

6.  A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy.

Authors:  Marian A J Weterman; Vincenzo Sorrentino; Paul R Kasher; Marja E Jakobs; Baziel G M van Engelen; Kees Fluiter; Marit B de Wissel; Aleksander Sizarov; Gudrun Nürnberg; Peter Nürnberg; Noam Zelcer; H Jurgen Schelhaas; Frank Baas
Journal:  Hum Mol Genet       Date:  2011-10-19       Impact factor: 6.150

Review 7.  An introduction to the molecular basis of inherited myelin diseases.

Authors:  J M Matthieu
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 8.  [Genetics of neuropathies].

Authors:  B Gess; A Schirmacher; P Young
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

9.  Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication.

Authors:  C A Wise; C A Garcia; S N Davis; Z Heju; L Pentao; P I Patel; J R Lupski
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

10.  Refined genetic mapping of X-linked Charcot-Marie-Tooth neuropathy.

Authors:  P R Fain; D F Barker; P F Chance
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.